Nurses' Notes
2045 — The client is a 68-year-old woman with type 2 diabetes and stage 3 chronic kidney disease. Her pneumonia is improving. She ate about 25 percent of dinner. Capillary glucose fell from 102 mg/dL at 1600 to 78 mg/dL at 2030. The 2100 medication administration record lists insulin degludec 24 units subcutaneously and insulin glargine 20 units subcutaneously as active. She denies sweating, tremor, palpitations, or confusion, is alert and oriented, has BP 126/72 mm Hg and HR 78/min, and states, "I use degludec at home, but I have never taken both long-acting insulins together."
Nurses' Notes
2045 — The client is a 68-year-old woman with type 2 diabetes and stage 3 chronic kidney disease. Her pneumonia is improving. She ate about 25 percent of dinner. Capillary glucose fell from 102 mg/dL at 1600 to 78 mg/dL at 2030. The 2100 medication administration record lists insulin degludec 24 units subcutaneously and insulin glargine 20 units subcutaneously as active. She denies sweating, tremor, palpitations, or confusion, is alert and oriented, has BP 126/72 mm Hg and HR 78/min, and states, "I use degludec at home, but I have never taken both long-acting insulins together."